Healthcare & Life Sciences
CollageBio
About
CollageBio develops gene-based therapeutics using an AI-enhanced polynucleotide engineering platform to create stable, specific, and programmable medicines that combine gene editing durability with safe and reversible disease modulation.
Explore CollageBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.